Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellengo
Vandœuvre-lès-Nancy, Franceplantadvanced.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cellengo is a wholly owned subsidiary of Plant Advanced Technologies PAT. It was created to industrialize the production of plant-derived biomolecules using microbial fermentation. The company leverages metabolic engineering to produce natural compounds that are otherwise only available in trace amounts from plants. Its eco-responsible approach aligns with green chemistry principles and aims at sustainable production for cosmetics, nutraceuticals, pharmaceuticals, and bio-pesticides markets. No clinical results are reported as it is primarily a technology/platform provider.
- Therapeutic areas
- Other
- Modalities
- Biologic (natural substances produced via microbial fermentation)Small molecule (plant-derived actives produced by engineered microbes)
- Industry
- Non-Drug Biotech
02
Partnerships
No major external partnerships disclosed; operates as a subsidiary of PAT.
Beyond the preview
Go deeper on Cellengo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellengo.